Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 24, 2023
Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 yearsYasmina Chouik, Olivier Chazouillères, Claire Francoz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary CholangitisAngela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2026
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort StudyFlorian Veyre, Claire Francoz, Domitille Erard, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
The American Journal of Gastroenterology|July 30, 2025
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 PatientsFlorian Veyre, Eleonora De Martin, Domitille Erard, et al.
The American Journal of Gastroenterology|July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline PhosphataseCarla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Journal of Hepatology|April 11, 2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitisChristophe Corpechot, Olivier Chazouillères, Pierre Belnou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|February 24, 2023
Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 yearsYasmina Chouik, Olivier Chazouillères, Claire Francoz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary CholangitisAngela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2026
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort StudyFlorian Veyre, Claire Francoz, Domitille Erard, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
The American Journal of Gastroenterology|July 30, 2025
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 PatientsFlorian Veyre, Eleonora De Martin, Domitille Erard, et al.
The American Journal of Gastroenterology|July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline PhosphataseCarla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Journal of Hepatology|April 11, 2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitisChristophe Corpechot, Olivier Chazouillères, Pierre Belnou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Pageof 12